Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -7.20% is 155% below its 5-year average of 13.02%, near the low end of its 5-year range (-7.20%–80.67%).
As of the fiscal period ended Thursday, April 30, 2026. 214.22% below its 12-month average of 6.31%.
Reported quarterly profit margin; no daily interpolation.
NET PROFIT MARGIN
-7.20%
NET PROFIT MARGIN AVG TTM
6.31%
NET PROFIT MARGIN AVG 3Y
9.81%
NET PROFIT MARGIN AVG 5Y
10.52%
NET PROFIT MARGIN AVG 10Y
12.49%
NET PROFIT MARGIN AVG 15Y
13.40%
NET PROFIT MARGIN AVG 20Y
11.92%
CURRENT VS TTM AVG
-214.22%
CURRENT VS 3Y AVG
-173.39%
CURRENT VS 5Y AVG
-168.44%
CURRENT VS 10Y AVG
-157.68%
CURRENT VS 15Y AVG
-153.77%
CURRENT VS 20Y AVG
-160.40%
SECTOR MEDIAN · HEALTHCARE
10.44%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-168.99%
vs the sector median at left
The Cooper Companies, Inc.
Market Cap
$14.05B
Net Profit Margin
-7.20%
TTM Avg
6.31%
3Y Avg
9.81%
5Y Avg
10.52%
Market Cap
$14.92B
Net Profit Margin
17.33%
TTM Avg
12.25%
3Y Avg
14.36%
5Y Avg
15.15%
Market Cap
$12.59B
Net Profit Margin
-9.70%
TTM Avg
-7.30%
3Y Avg
-3.29%
5Y Avg
1.14%
Market Cap
$12.58B
Net Profit Margin
10.50%
TTM Avg
10.36%
3Y Avg
10.48%
5Y Avg
22.21%
Market Cap
$15.94B
Net Profit Margin
17.67%
TTM Avg
18.50%
3Y Avg
17.20%
5Y Avg
16.74%
Market Cap
$11.58B
Net Profit Margin
-4.59%
TTM Avg
-1.67%
3Y Avg
5.09%
5Y Avg
7.31%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| The Cooper Companies, Inc. (COO) | $14.05B | -7.20% | 6.31% | 9.81% | 10.52% |
| Solventum Corporation (SOLV)vs › | $14.92B | 17.33% | 12.25% | 14.36% | 15.15% |
| DaVita Inc. (DVA)vs › | $15.37B | 5.65% | 6.39% | 5.83% | 6.41% |
| Baxter International Inc. (BAX)vs › | $12.59B | -9.70% | -7.30% | -3.29% | 1.14% |
| Align Technology, Inc. (ALGN)vs › | $12.58B | 10.50% | 10.36% | 10.48% | 22.21% |
| Revvity, Inc. (RVTY)vs › | $12.44B | 8.30% | 9.60% | 8.02% | 12.66% |
| Medpace Holdings, Inc. (MEDP)vs › | $15.94B | 17.67% | 18.50% | 17.20% | 16.74% |
| Insulet Corp. (PODD)vs › | $11.60B | 10.44% | 14.66% | 10.46% | 7.35% |
| Charles River Laboratories International, Inc. (CRL)vs › | $11.58B | -4.59% | -1.67% | 5.09% | 7.31% |
| Bio-Techne Corporation (TECH)vs › | $11.28B | 9.05% | 10.26% | 17.56% | 19.39% |
Operating Margin
11.8%
Net Profit Margin
-7.2%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-04-30 | -7.20% |
| 2026-01-31 | 12.77% |
| 2025-10-31 | 7.94% |
| 2025-07-31 | 9.27% |
| 2025-04-30 | 8.75% |
| 2025-01-31 | 10.81% |
| 2024-10-31 | 11.54% |
| 2024-07-31 | 10.44% |
| 2024-04-30 | 9.43% |
| 2024-01-31 | 8.72% |
| 2023-10-31 | 9.11% |
| 2023-07-31 | 9.17% |
| 2023-04-30 | 4.54% |
| 2023-01-31 | 9.85% |
| 2022-10-31 | 7.73% |
| 2022-07-31 | 11.67% |
| 2022-04-30 | 15.26% |
| 2022-01-31 | 12.11% |
| 2021-10-31 | 14.53% |
| 2021-07-31 | 80.67% |
| 2021-04-30 | 16.33% |
| 2021-01-31 | 308.76% |
| 2020-10-31 | 11.91% |
| 2020-07-31 | 9.55% |
| 2020-04-30 | 2.19% |
| 2020-01-31 | 14.00% |
| 2019-10-31 | 17.50% |
| 2019-07-31 | 17.68% |
| 2019-04-30 | 18.71% |
| 2019-01-31 | 16.43% |
| 2018-10-31 | 15.44% |
| 2018-07-31 | 15.27% |
| 2018-04-30 | 9.65% |
| 2018-01-31 | -20.76% |
| 2017-10-31 | 15.78% |
| 2017-07-31 | 18.63% |
| 2017-04-30 | 20.08% |
| 2017-01-31 | 15.19% |
| 2016-10-31 | 11.67% |
| 2016-07-31 | 17.08% |
| 2016-04-30 | 15.32% |
| 2016-01-31 | 11.42% |
| 2015-10-31 | 8.05% |
| 2015-07-31 | 9.74% |
| 2015-04-30 | 13.97% |
| 2015-01-31 | 13.74% |
| 2014-10-31 | 6.58% |
| 2014-07-31 | 20.36% |
| 2014-04-30 | 19.20% |
| 2014-01-31 | 17.74% |
| 2013-10-31 | 13.94% |
| 2013-07-31 | 21.59% |
| 2013-04-30 | 19.56% |
| 2013-01-31 | 19.66% |
| 2012-10-31 | 18.15% |
| 2012-07-31 | 17.68% |
| 2012-04-30 | 15.94% |
| 2012-01-31 | 16.75% |
| 2011-10-31 | 15.69% |
| 2011-07-31 | 10.85% |
| 2011-04-30 | 10.87% |
| 2011-01-31 | 15.45% |
| 2010-10-31 | 15.38% |
| 2010-07-31 | 13.44% |
| 2010-04-30 | 1.54% |
| 2010-01-31 | 7.85% |
| 2009-10-31 | 10.63% |
| 2009-07-31 | 7.68% |
| 2009-04-30 | 9.46% |
| 2009-01-31 | 9.51% |
| 2008-10-31 | 10.97% |
| 2008-07-31 | 6.25% |
| 2008-04-30 | 4.27% |
| 2008-01-31 | 2.81% |
| 2007-10-31 | -9.53% |
| 2007-07-31 | 3.25% |
| 2007-04-30 | -0.23% |
| 2007-01-31 | 2.44% |
| 2006-10-31 | 6.30% |
| 2006-07-31 | 9.29% |
| 2006-04-30 | 6.48% |
| 2006-01-31 | 8.73% |
| 2005-10-31 | 2.88% |
| 2005-07-31 | 16.82% |
| 2005-04-30 | 13.68% |
| 2005-01-31 | 12.50% |
| 2004-10-31 | 21.96% |
| 2004-07-31 | 18.63% |
| 2004-04-30 | 18.00% |
| 2004-01-31 | 16.73% |
| 2003-10-31 | 18.63% |
| 2003-07-31 | 17.21% |
| 2003-04-30 | 15.78% |
| 2003-01-31 | 14.74% |
| 2002-10-31 | 17.09% |
| 2002-07-31 | 14.75% |
